Article · 13 Oct 2026
Review articlePublished 10 Apr 2017
Fixed Dose Combination of Arterolane and Piperaquine: A Newer Prospect in Antimalarial Therapy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Malaria has been very prevalent vector borne disease in India and until date bears enormous implications on health care services of the country. Over the period of time, the development of resistance to traditional antimalarials like chloroquine has been posed as major deterrent in efforts of malaria control. As the drug resistance is today universally prevalent, especially in Plasmodium falciparum species, major burden of malarial control resides with the new artemisinin drug class. However, arterolane is one of the first fully synthetic non-artemisinin antimalarial compound with rapid schizontocidal activity, hence offering an alternative to artemisinin drugs in malaria control. Piperaquine is a synthetic bisquinoline (4-amioquinoline Antimalarial) with slow and longer schizontocidal activity. Therefore their combination has been shown to provide rapid parasitemic clearance and quick relief of most malaria related symptoms along with prevention of recrudescences. This combination was approved by Drugs Controller General of India in 2011 for treatment of uncomplicated P. falciparum malaria. The article is aimed at to review this newer prospect in antimalarial therapy for which comprehensive database search was done in Google, Google Scholar, PubMed using the terms “Malaria,” “Arterolane,” “OZ277,” “Piperaquine,” and “Artemisinin combination therapy.” A total of 323 articles were screened and 28 articles were considered for this review along with the World Health Organization and National malarial program guidelines.
Keywords
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Annals of Medical and Health Sciences Research.
Article · 10 Jun 2026
Understanding High-Functioning Depression: A Narrative Review of Diagnostic Challenges, Nosological Frameworks, and Clinical Implications
Article · 14 Apr 2026
An Open-Label Clinical Study On Safety And Gastrointestinal Tolerance Of Maxvida™ High Protein In Hospitalized Adults Requiring Isocaloric Enteral Feeding
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAnnals of Medical and Health Sciences Research
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Patil CY”
- BylineArticles whose byline prints “Katare SS”
- BylineArticles whose byline prints “Baig MS”
- BylineArticles whose byline prints “Doifode SM”